Blogs | Visikol

Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research

Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]

Griffin Ferrara2021-01-08T15:14:13-05:00

We are excited to finally turn the page on 2020 and get started on 2021 and are looking forward [...]

Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]

Over the last decade there has been a boom of companies looking into immunotherapies for treating cancer [...]

Immuno-oncology is an exciting field of research that is focused on developing therapeutics the leverage the immune system to [...]

The retina is a vital sheet of nerve tissue at the back of the eye, transforming light signals into [...]

Drug-induced liver injury (DILI) is one of the most frequent causes of safety-related drug marketing withdrawal, according to the [...]

Visikol added the Leica Biosystems’ Aperio VERSA 8 slide scanner to its services as the company expands its suite [...]

Visikol, a leading provider of advanced cell culture assay services, has recently expanded its portfolio of in vitro assays [...]

Cellular migration plays an integral role in the development and maintenance of many biological processes present in multicellular organisms. [...]